Riad Dirani, PhD, is currently the VP of Global Health Economic and Outcomes Research at Teva Pharmaceuticals. His responsibilities include overseeing the establishment of this function within Medical Affairs, and developing the strategic capabilities for HEOR to optimize the development and commercialization of Teva’s portfolio of products and offerings globally.
Riad has worked in the pharmaceutical industry since 2000, including positions of increasing responsibility at Aventis, GlaxoSmithKline, Pfizer, and Johnson & Johnson in multiple therapeutic areas. Riad joined Teva in 2014 to build the global HEOR group and establish its operating model.
Riad received his Ph.D. in Health Services Research/Health Economics from The Pennsylvania State University. He has published over 25 journal articles and made numerous presentations to professional organizations, including the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and therapeutic-specific conferences.
1) US payer introduction to the structures and processes